XPhyto supplied 10 test centers in Berlin with 25-minute COVID-19 PCR test
On Jun. 30, 2021, XPhyto announces that it had signed a master supply agreement with Beovita GmbH &…
On Jun. 30, 2021, XPhyto announces that it had signed a master supply agreement with Beovita GmbH &…
On Jun. 28, 2021, researchers running the University of Oxford-led Com-COV study reported that alternating doses of the…
On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
On May 24, 2021, Pfizer announced that the first enrolled subjects had received their immunizations as part of…
On May 20, 2021, XPhyto announced announced it had commenced a pilot project with its rapid COVID-19 PCR…
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
On May 20, 2021, Pfizer and BioNTech announced an agreement with Turkey’s Ministry of Health to supply 60…
On May 13, 2021, University of Oxford researchers reported that Com-COV study data comparing mixed dosing schedules of…
On May 10, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On May 7, 2021, Pfizer and BioNTech announced the initiation of a Biologics License Application (BLA) with the…
On May 5, 2021, the World Health Organization (WHO) and the Federal Republic of Germany announced a new…
On May 5, 2021, Pfizer and BioNTech announced that Health Canada had expanded the Interim Order authorization for…
On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…
On Apr. 28, 2021, the Centers for Disease Control and Prevention (CDC) announced that both mRNA COVID-19 vaccines…
On Apr. 23, 2021, University of Oxford data from the COVID-19 Infection Survey was the first to show…
On Apr. 19, 2021, Pfizer and BioNTech announced supplying an additional 100 million doses of COMIRNATY, the companies…
On Apr. 7, 2021, the National Institutes of Health (NIH) announced that a clinical trial is underway to determine…
On Mar. 26, 2021, Pfizer and BioNTech announced that the European Medicines Agency (EMA) approved storage of COMIRNATY…
On Mar. 26, 2021, Bristol Myers Squibb and bluebird bio announced that the U.S. Food and Drug Administration…
On Mar. 26, 2021, BioNTech announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19…
On Mar. 18, 2021, XPhyto and its exclusive German diagnostics development partner, 3a-diagnostics, are pleased to announce the…
On Mar. 11, 2021, the Israel Ministry of Health (MOH), Pfizer and BioNTech announced real-world evidence demonstrating dramatically…
On Mar. 6, 2021, Moderna announced a supply agreement with the Government of The Philippines for 13 million doses…
On Mar. 3, 2021, Pfizer and BioNTech, in partnership with UNICEF, announced the arrival of the first doses…
On Feb. 17, 2021, BioNTech announced an agreement with the European Commission (EC) to supply an additional 200 million…
On Dec. 16, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced an agreement to supply Mainland China with an…
On Dec. 14, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that the New Orleans and Bedford,…
On Dec. 1, 2020, Pfizer and BioNTech announced they had submitted on Monday, November 30, 2020, a formal…
On Nov. 25, 2020, BioNTech and Shanghai Fosun Pharmaceutica jointly announced that their lead mRNA COVID-19 vaccine candidate…